The network was established to assess the implications and impacts of pollution and contaminants on the health of Arctic residents. The biomonitoring program monitors concentrations of contaminants in human tissues in the eight circumpolar nations and assesses spatial and temporal patterns/trends and potential health effects at present and future levels. Where available, contaminant guidelines are used to evaluate risk to populations/communities. AMAP has been designed to have roots in the national programs of participating countries. Main gaps: Trend data of legacy POPs and metals is available, though some communities have only two sampling periods, further monitoing is planned; measurements of tissue concentrations of emerging contaminants and personal care products is just starting and needs to be continued; health effects research needs to be expanded to other regions with high exposure (e.g., arctic Russia). Network type: - Thematical observations: Contaminant concentrations and health effects data - Field stations: None, community / population based research. - Community based observations: Participation of community health workers and community residents for data collection through tissue samples - Coordination: Human Health Assessment Group (HHAG) was created bringing together leading researchers and research coordinators from eight circumpolar countries; AMAP Ring Test (QA/QC program) coordinates and standardizes laboratories for analyzing biomonitoring samples.
Concentrations of contaminants in maternal blood and breast milk across all eight circumpolar regions; concentrations of contaminants in Inuit men and women in Nunavik (Canada), Greenland, and Russia. Not all of the countries monitor the same contaminants. The contaminants measured include: • Persistent organic pollutants (POPs) - oxychlordane - trans-nonachlor - p,p’-DDT - p,p’-DDE -toxaphene (parlars 26, 50) - polychlorinated biphenyls (PCBs 99, 118, 138, 153, 180, Aroclor 1260, Σ14 PCBs) - hexachlorobenzene (HCB) - mirex • Heavy metals - total and organic mercury - lead - cadmium - selenium • Emerging contaminants, pharmaceutics, personal care products - e.g. - Polybrominated diphenyl ethers (PBDEs 47, 99, 100, 153, 183, 209) - perfluorooctane sulfonate (PFOS) - perfluorooctanoic acid (PFOA) - Tetrabromobisphenol A (TBBPA) - pentachlorophenol (PCP) - hydroxylated PCBs (107, 146, 187) • Broad range of health effects research (see AMAP reports) - Immune - Neurodevelopmental - Cardiovascular - Metabolic – obesity/diabetes
Human Health Assessment Group (HHAG) was created bringing together leading researchers and research coordinators from eight circumpolar countries; AMAP Ring Test (QA/QC program) coordinates and standardizes laboratories for analyzing biomonitoring samples. Networks: Arctic Monitoring and Assessment Programme (AMAP)
Participation of community health workers and community residents for data collection through tissue samples